The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Tumor Microenvironment as A “Game Changer” in Cancer Radiotherapy
Open accessAbstract
Radiotherapy (RT), besides cancer cells, also affects the tumor microenvironment (TME): tumor blood vessels and cells of the immune system. It damages endothelial cells and causes radiation-induced inflammation. Damaged vessels inhibit the infiltration of CD8+ T lymphocytes into tumors, and immunosuppressive pathways are activated. They lead to the accumulation of radioresistant suppressor cells, including tumor-associated macrophages (TAMs) with the M2 phenotype, myeloid-derived suppressor cells (MDSCs), and regulatory T cells (Tregs). The area of tumor hypoxia increases. Hypoxia reduces oxygen-dependent DNA damage and weakens the anti-cancer RT effect. It activates the formation of new blood vessels and leads to cancer relapse after irradiation. Irradiation may also activate the immune response through immunogenic cell death induction. This leads to the “in situ” vaccination effect. In this article, we review how changes in the TME affect radiation-induced anticancer efficacy. There is a very delicate balance between the activation of the immune system and the immunosuppression induced by RT. The effects of RT doses on immune system reactions and also on tumor vascularization remain unclear. A better understanding of these interactions will contribute to the optimization of RT treatment, which may prevent the recurrence of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Elements of cancer immunity and the cancer–immune set point
Chen, D. S., & Mellman, I. (2017) · Nature · doi:10.1038/nature21349 · Cited by 5,352
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632 · cited 1×
“Cells of the immune system include tumor-associated macrophages (TAMs) with the M2 phenotype, tumor-associated neutrophils (TANs) with the N2 phenotype, MDSCs (myeloid-derived suppressor cells), mast cells, and natural killer (NK) cells, producing a variety of factors (chemokines, cytokines, and enzymes) that directly…”
BackgroundThe Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
Tumour-associated macrophages as treatment targets in oncology
Mantovani, A., Marchesi, F., Malesci, A., Laghi, L., & Allavena, P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.217 · Cited by 4,033
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Galon, J., & Bruni, D. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0007-y · Cited by 3,409
(1989) · PubMed · Cited by 3,343
STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
Ishikawa, H., Ma, Z., & Barber, G. N. (2009) · Nature · doi:10.1038/nature08476 · Cited by 2,759 · cited 1×
“IR also induces the production of IFN (type I) by activating a stimulator of interferon genes (STING) pathway in tumor-infiltrating DCs, as well as the increased secretion of CXCL10, a C-X-C chemokine receptor (CXCR3+) that recruits IFN-γ secreting CD8+ T cells [34,75].”
BackgroundDistinct role of macrophages in different tumor microenvironments
Lewis, C. E., & Pollard, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4005 · Cited by 2,225
The Tumour Microenvironment after Radiotherapy: Mechanisms of Resistance and Recurrence
Barker, H. E., Paget, J. T. E., Khan, A. A., & Harrington, K. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3958 · Cited by 2,144 · cited 12×
“Understanding the effect of radiotherapy on the functionality of tumor vasculature is important to maximize the effectiveness of radiotherapy [56].”
BackgroundInfluentialCancer as an evolutionary and ecological process
Merlo, L. M. F., Pepper, J. W., Reid, B. J., & Maley, C. C. (2006) · Nature Reviews Cancer · doi:10.1038/nrc2013 · Cited by 1,699
Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis
Garcia-Barros, M., Paris, F., Cordon-Cardo, C., Lyden, D., Rafii, S., Haimovitz-Friedman, A., Fuks, Z., & Kolesnick, R. (2003) · Science · doi:10.1126/science.1082504 · Cited by 1,593
Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
Chanmee, T., Ontong, P., Konno, K., & Itano, N. (2014) · Cancers · doi:10.3390/cancers6031670 · Cited by 1,538
Tumor angiogenesis and vascular normalization: alternative therapeutic targets
Viallard, C., & Larrivée, B. (2017) · Angiogenesis · doi:10.1007/s10456-017-9562-9 · Cited by 1,424
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated
Demaria, S., Ng, B., Devitt, M. L., Babb, J. S., Kawashima, N., Liebes, L., & Formenti, S. C. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.09.012 · Cited by 1,388
Whole Body Irradiation—Radiobiology or Medicine?
Mole, R. H. (1953) · The British Journal of Radiology · doi:10.1259/0007-1285-26-305-234 · Cited by 1,123
Huang, Y., Yuan, J., Righi, E., Kamoun, W. S., Ancukiewicz, M., Nezivar, J., Santosuosso, M., Martin, J. D., Martin, M. R., Vianello, F., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215397109 · Cited by 1,099
Klug, F., Prakash, H., Huber, P. E., Seibel, T., Bender, N., Halama, N., Pfirschke, C., Voss, R. H., Timke, C., Umansky, L., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.09.014 · Cited by 1,099
Radiotherapy and immunotherapy: a beneficial liaison?
Weichselbaum, R. R., Liang, H., Deng, L., & Fu, Y.-X. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.211 · Cited by 1,070
Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift
Formenti, S. C., & Demaria, S. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs629 · Cited by 1,053
Hypoxia-Inducible Factors: Master Regulators of Cancer Progression
Schito, L., & Semenza, G. L. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2016.10.016 · Cited by 962 · cited 1×
“It is a regulator of cancer hallmarks [22,23].”
BackgroundMurdoch, C., Giannoudis, A., & Lewis, C. E. (2004) · Blood · doi:10.1182/blood-2004-03-1109 · Cited by 915
Burnette, B. C., Liang, H., Lee, Y., Chlewicki, L., Khodarev, N. N., Weichselbaum, R. R., Fu, Y.-X., & Auh, S. L. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2820 · Cited by 878
Opportunities and challenges of radiotherapy for treating cancer
Schaue, D., & McBride, W. H. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.120 · Cited by 784
Rolny, C., Mazzone, M., Tugues, S., Laoui, D., Johansson, I., Coulon, C., Squadrito, M. L., Segura, I., Li, X., Knevels, E., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.11.009 · Cited by 695
Biological response of cancer cells to radiation treatment
Baskar, R., Dai, J., Wenlong, N., Yeo, R., & Yeoh, K.-W. (2014) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2014.00024 · Cited by 638
Tumor Microenvironment Complexity: Emerging Roles in Cancer Therapy
Swartz, M. A., Iida, N., Roberts, E. W., Sangaletti, S., Wong, M. H., Yull, F. E., Coussens, L. M., & DeClerck, Y. A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0122 · Cited by 542
TGFβ is a master regulator of radiation therapy-induced antitumor immunity
Vanpouille-Box, C., Diamond, J. M., Pilones, K. A., Zavadil, J., Babb, J. S., Formenti, S. C., Barcellos-Hoff, M. H., & Demaria, S. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3511 · Cited by 514
Radiotherapy combination opportunities leveraging immunity for the next oncology practice
Herrera, F. G., Bourhis, J., & Coukos, G. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21358 · Cited by 509
Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect
Rodríguez-Ruiz, M. E., Vanpouille-Box, C., Melero, I., Formenti, S. C., & Demaria, S. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.06.001 · Cited by 497
Radiotherapy and the Tumor Stroma: The Importance of Dose and Fractionation
Hellevik, T., & Martinez-Zubiaurre, I. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00001 · Cited by 442
Ahn, G.-O., & Brown, J. M. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.11.032 · Cited by 432
Maier, P., Hartmann, L., Wenz, F., & Herskind, C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010102 · Cited by 414
Albini, A., Bruno, A., Noonan, D. M., & Mortara, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00527 · Cited by 392
Wang, Y., Deng, W., Li, N., Neri, S., Sharma, A., Jiang, W., & Lin, S. H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00185 · Cited by 374
Regnier, R. (1992) · PubMed · Cited by 362
Cell adhesion molecules mediate radiation-induced leukocyte adhesion to the vascular endothelium.
Hallahan, D. E., Kuchibhotla, J., & Wyble, C. W. (1996) · PubMed · Cited by 358
Radiation-Induced Endothelial Vascular Injury
Venkatesulu, B. P., Mahadevan, L. S., Aliru, M. L., Yang, X., Bodd, M. H., Singh, P. K., Yusuf, S. W., Abe, J.-I., & Krishnan, S. (2018) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2018.01.014 · Cited by 334
Immunomodulation of the Tumor Microenvironment: Turn Foe Into Friend
Locy, H., de Mey, S., de Mey, W., De Ridder, M., Thielemans, K., & Maenhout, S. K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02909 · Cited by 279
Kozin, S. V., Kamoun, W. S., Huang, Y., Dawson, M. R., Jain, R. K., & Duda, D. G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4446 · Cited by 277
The Effect of Radiation on the Immune Response to Cancers
Park, B., Yee, C., & Lee, K.-M. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15010927 · Cited by 272
Tsai, C.-S., Chen, F.-H., Wang, C.-C., Huang, H.-L., Jung, S.-M., Wu, C.-J., Lee, C.-C., McBride, W. H., Chiang, C.-S., & Hong, J.-H. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.01.041 · Cited by 257
Qiu, G.-Z., Jin, M.-Z., Dai, J.-X., Sun, W., Feng, J.-H., & Jin, W.-L. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.05.002 · Cited by 245
Radiation effects on antitumor immune responses: current perspectives and challenges
Walle, T., Martinez Monge, R., Cerwenka, A., Ajona, D., Melero, I., & Lecanda, F. (2018) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834017742575 · Cited by 243
Radiotherapy and immune response: the systemic effects of a local treatment
de Andrade Carvalho, H., & Villar, R. C. (2018) · Clinics · doi:10.6061/clinics/2018/e557s · Cited by 238
Intratumoral hypoxia, radiation resistance, and HIF-1
Semenza, G. L. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00118-7 · Cited by 235
The controversial abscopal effect
Kaminski, J. M., Shinohara, E., Summers, J. B., Niermann, K. J., Morimoto, A., & Brousal, J. (2005) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2005.03.004 · Cited by 229
Targeting immune cells for cancer therapy
Gun, S. Y., Lee, S. W. L., Sieow, J. L., & Wong, S. C. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101174 · Cited by 229
Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity
Hoves, S., Ooi, C.-H., Wolter, C., Sade, H., Bissinger, S., Schmittnaegel, M., Ast, O., Giusti, A. M., Wartha, K., Runza, V., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20171440 · Cited by 219
Ionizing Radiation-Induced Endothelial Cell Senescence and Cardiovascular Diseases
Wang, Y., Boerma, M., & Zhou, D. (2016) · Radiation Research · doi:10.1667/rr14445.1 · Cited by 203
Hypoxic Radioresistance: Can ROS Be the Key to Overcome It?
Wang, H., Jiang, H., Van De Gucht, M., & De Ridder, M. (2019) · Cancers · doi:10.3390/cancers11010112 · Cited by 203
Bystander effects and radiotherapy
Marín, A., Martín, M., Liñán, O., Alvarenga, F., López, M., Fernández, L., Büchser, D., & Cerezo, L. (2015) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/j.rpor.2014.08.004 · Cited by 197
The Tumor Vascular Endothelium as Decision Maker in Cancer Therapy
Klein, D. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00367 · Cited by 196
Barriers to Radiation-Induced In Situ Tumor Vaccination
Wennerberg, E., Lhuillier, C., Vanpouille-Box, C., Pilones, K. A., García-Martínez, E., Rudqvist, N.-P., Formenti, S. C., & Demaria, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00229 · Cited by 194
Radiation, inflammation and the immune response in cancer
McKelvey, K. J., Hudson, A. L., Back, M., Eade, T., & Diakos, C. I. (2018) · Mammalian Genome · doi:10.1007/s00335-018-9777-0 · Cited by 192
Dying cell clearance and its impact on the outcome of tumor radiotherapy
Lauber, K., Ernst, A., Orth, M., Herrmann, M., & Belka, C. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00116 · Cited by 187
The Reciprocity between Radiotherapy and Cancer Immunotherapy
Wang, Y., Liu, Z.-G., Yuan, H., Deng, W., Li, J., Huang, Y., Kim, B. Y. S., Story, M. D., & Jiang, W. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2581 · Cited by 181
Frey, B., Rückert, M., Deloch, L., Rühle, P. F., Derer, A., Fietkau, R., & Gaipl, U. S. (2017) · Immunological Reviews · doi:10.1111/imr.12572 · Cited by 180
Tariq, M., Zhang, J., Liang, G., Ding, L., He, Q., & Yang, B. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25895 · Cited by 178
Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity
Martin, J. D., Fukumura, D., Duda, D. G., Boucher, Y., & Jain, R. K. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a027094 · Cited by 175
Role of T lymphocytes in tumor response to radiotherapy
Demaria, S., & Formenti, S. C. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00095 · Cited by 174
Targeting DNA Double-Strand Break Repair Pathways to Improve Radiotherapy Response
Toulany, M. (2019) · Genes · doi:10.3390/genes10010025 · Cited by 173
Novel Approaches to Improve the Efficacy of Immuno-Radiotherapy
Shevtsov, M., Sato, H., Multhoff, G., & Shibata, A. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00156 · Cited by 173
Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment
Menon, H., Ramapriyan, R., Cushman, T. R., Verma, V., Kim, H. H., Schoenhals, J. E., Atalar, S. C., Selek, U., Chun, S. G., Chang, J. Y., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00193 · Cited by 170
Immune targets in the tumor microenvironment treated by radiotherapy
Ozpiskin, O. M., Zhang, L., & Li, J. J. (2019) · Theranostics · doi:10.7150/thno.32648 · Cited by 163
The Impact of Radiation on the Tumor Microenvironment: Effect of Dose and Fractionation Schedules
Arnold, K. M., Flynn, N. J., Raben, A., Romak, L., Yu, Y., Dicker, A. P., Mourtada, F., & Sims-Mourtada, J. (2018) · Cancer Growth and Metastasis · doi:10.1177/1179064418761639 · Cited by 162
Modern Radiotherapy Concepts and the Impact of Radiation on Immune Activation
Deloch, L., Derer, A., Hartmann, J., Frey, B., Fietkau, R., & Gaipl, U. S. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00141 · Cited by 161
The Abscopal Effect of Radiation Therapy: What Is It and How Can We Use It in Breast Cancer?
Hu, Z. I., McArthur, H. L., & Ho, A. Y. (2017) · Current Breast Cancer Reports · doi:10.1007/s12609-017-0234-y · Cited by 160
Derer, A., Frey, B., Fietkau, R., & Gaipl, U. S. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1771-8 · Cited by 158
Frey, B., Rubner, Y., Wunderlich, R., Weiss, E., Pockley, A. G., Fietkau, R., & Gaipl, U. S. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800099811 · Cited by 154
Antitumor immune responses induced by ionizing irradiation and further immune stimulation
Frey, B., Rubner, Y., Kulzer, L., Werthmöller, N., Weiss, E., Fietkau, R., & Gaipl, U. S. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1474-y · Cited by 150
Manda, K., Glasow, A., Paape, D., & Hildebrandt, G. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00102 · Cited by 144
Cui, Y. R., & Guo, G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111942 · Cited by 140
Myeloid-Derived Cells in Tumors: Effects of Radiation
Vatner, R. E., & Formenti, S. C. (2014) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2014.07.008 · Cited by 139
Wirsdörfer, F., de Leve, S., & Jendrossek, V. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010024 · Cited by 138
Ionizing radiation-induced cellular senescence promotes tissue fibrosis after radiotherapy. A review
Nguyen, H. Q., To, N. H., Zadigue, P., Kerbrat, S., TAILLE, A. D. L., Gouvello, S. L., & Belkacémi, Y. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.06.012 · Cited by 137
Radiation triggering immune response and inflammation
Hekim, N., Çetin, Z., Nikitaki, Z., Çört, A., & Saygılı, E. İ. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.04.016 · Cited by 131
Vasculogenesis: a crucial player in the resistance of solid tumours to radiotherapy
Brown, J. M. (2013) · British Journal of Radiology · doi:10.1259/bjr.20130686 · Cited by 127
The role of tumor-associated macrophages in tumor vascularization
Guo, C., Buranych, A., Sarkar, D., Fisher, P. B., & Wang, X. (2013) · Vascular Cell · doi:10.1186/2045-824x-5-20 · Cited by 126
Gamma-Ray Resistance of Regulatory CD4+CD25+Foxp3+ T Cells in Mice
Qu, Y., Jin, S., Zhang, A., Zhang, B., Shi, X.-Y., Wang, J.-J., & Zhao, Y. (2010) · Radiation Research · doi:10.1667/rr0978.1 · Cited by 125
Klammer, H., Mladenov, E., Li, F., & Iliakis, G. E. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.12.017 · Cited by 124
Immune modulatory effects of radiotherapy as basis for well-reasoned radioimmunotherapies
Rückert, M., Deloch, L., Fietkau, R., Frey, B., Hecht, M., & Gaipl, U. S. (2018) · Strahlentherapie und Onkologie · doi:10.1007/s00066-018-1287-1 · Cited by 124
The effect of ionizing radiation on regulatory T cells in health and disease
Persa, E., Balogh, A., Sáfrány, G., & Lumniczky, K. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.03.003 · Cited by 123
The synergistic effect of radiotherapy and immunotherapy: A promising but not simple partnership
Chajon, É., Castelli, J., Marsiglia, H. R., & de Crevoisier, R. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.01.017 · Cited by 121
Hypoxic Stress-Induced Tumor and Immune Plasticity, Suppression, and Impact on Tumor Heterogeneity
Terry, S., Buart, S., & Chouaïb, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01625 · Cited by 117
Molecular mechanism of bystander effects and related abscopal/cohort effects in cancer therapy
Wang, R., Zhou, T., Liu, W., & Zuo, L. (2018) · Oncotarget · doi:10.18632/oncotarget.24746 · Cited by 117
Molecular Biology for the Radiation Oncologist: the 5Rs of Radiobiology meet the Hallmarks of Cancer
Harrington, K. J., Jankowska, P., & Hingorani, M. (2007) · Clinical Oncology · doi:10.1016/j.clon.2007.04.009 · Cited by 115
Falcke, S. E., Rühle, P. F., Deloch, L., Fietkau, R., Frey, B., & Gaipl, U. S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113574 · Cited by 113
Awakening the immune system with radiation: Optimal dose and fractionation
Gandhi, S. J., Minn, A. J., Vonderheide, R. H., Wherry, E. J., Hahn, S. M., & Maity, A. M. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.03.024 · Cited by 112
Present and future of cancer immunotherapy: A tumor microenvironmental perspective (Review)
Yu, Y., & Cui, J. (2018) · Oncology Letters · doi:10.3892/ol.2018.9219 · Cited by 108
Innate immunity, inflammation and tumour progression: double‐edged swords
Mantovani, A., Ponzetta, A., Inforzato, A., & Jaillon, S. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12886 · Cited by 107
In Situ Vaccination for the Treatment of Cancer
Hammerich, L., Bhardwaj, N., Kohrt, H. E. K., & Brody, J. (2016) · Immunotherapy · doi:10.2217/imt.15.120 · Cited by 105
The Hallmarks of Cancer and the Radiation Oncologist: Updating the 5Rs of Radiobiology
Good, J., & Harrington, K. J. (2013) · Clinical Oncology · doi:10.1016/j.clon.2013.06.009 · Cited by 102
The role of macrophage phenotype in regulating the response to radiation therapy
Shi, X., & Shiao, S. L. (2017) · Translational research · doi:10.1016/j.trsl.2017.11.002 · Cited by 102
Gupta, K., & Burns, T. C. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00503 · Cited by 101
Hypoxia and Predicting Radiation Response
Hill, R. P., Bristow, R. G., Fyles, A., Koritzinsky, M., Milosevic, M., & Wouters, B. G. (2015) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2015.05.004 · Cited by 98
Induction of a Senescence-Like Phenotype in Bovine Aortic Endothelial Cells by Ionizing Radiation
Oh, C. W., Bump, E. A., Kim, J.-S., Janigro, D., & Mayberg, M. R. (2001) · Radiation Research · doi:10.1667/0033-7587(2001)156[0232:ioaslp]2.0.co;2 · Cited by 94
Macrophages in radiation injury: a new therapeutic target
Meziani, L., Deutsch, É., & Mondini, M. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1494488 · Cited by 94
Ramamonjisoa, N., & Ackerstaff, E. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00003 · Cited by 93 · cited 1×
“Cells of the immune system include tumor-associated macrophages (TAMs) with the M2 phenotype, tumor-associated neutrophils (TANs) with the N2 phenotype, MDSCs (myeloid-derived suppressor cells), mast cells, and natural killer (NK) cells, producing a variety of factors (chemokines, cytokines, and enzymes) that directly…”
BackgroundImmune recognition of irradiated cancer cells
Wennerberg, E., Vanpouille‐Box, C., Bornstein, S., Yamazaki, T., Demaria, S., & Galluzzi, L. (2017) · Immunological Reviews · doi:10.1111/imr.12568 · Cited by 92
Potiron, V. A., Abderrahmani, R., Clément-Colmou, K., Marionneau‐Lambot, S., Oullier, T., Paris, F., & Supiot, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084076 · Cited by 89
M1-like macrophages change tumor blood vessels and microenvironment in murine melanoma
Jarosz–Biej, M., Kamińska, N., Matuszczak, S., Cichoń, T., Pamuła‐Piłat, J., Czapla, J., Smolarczyk, R., Skwarzyńska, D., Kulik, K., & Szala, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191012 · Cited by 88
Self-citationThe renaissance of anti‐neoplastic immunity from tumor cell demise
Ma, Y., Pitt, J. M., Li, Q., & Yang, H. (2017) · Immunological Reviews · doi:10.1111/imr.12586 · Cited by 87
STING Signaling in Cancer Cells: Important or Not?
Sokołowska, O., & Nowis, D. (2017) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-017-0481-7 · Cited by 85
How Does Ionizing Irradiation Contribute to the Induction of Anti-Tumor Immunity?
Rubner, Y., Wunderlich, R., Rühle, P.-F., Kulzer, L., Werthmöller, N., Frey, B., Weiss, E., Keilholz, L., Fietkau, R., & Gaipl, U. S. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00075 · Cited by 84
T lymphocytes and normal tissue responses to radiation
Schaue, D., & McBride, W. H. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00119 · Cited by 80
Ostrand‐Rosenberg, S., Horn, L. A., & Ciavattone, N. G. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00215 · Cited by 77
Combining angiogenesis inhibition and radiotherapy: A double-edged sword
Kleibeuker, E. A., Griffioen, A. W., Verheul, H. M. W., Slotman, B. J., & Thijssen, V. L. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.04.002 · Cited by 75
Radiation-induced immune responses: mechanisms and therapeutic perspectives
Jeong, H., Bok, S., Hong, B.-J., Choi, H.-S., & Ahn, G. (2016) · Blood Research · doi:10.5045/br.2016.51.3.157 · Cited by 74
cGAS/STING Pathway in Cancer: Jekyll and Hyde Story of Cancer Immune Response
Bose, D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112456 · Cited by 70
In situ vaccination: Harvesting low hanging fruit on the cancer immunotherapy tree
Sheen, M. R., & Fiering, S. (2018) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1524 · Cited by 69
The Immunoregulatory Potential of Particle Radiation in Cancer Therapy
Ebner, D. K., Tinganelli, W., Helm, A., Bisio, A., Yamada, S., Kamada, T., Shimokawa, T., & Durante, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00099 · Cited by 66
Paradigm shift in oncology: targeting the immune system rather than cancer cells
Shekarian, T., Valsesia‐Wittmann, S., Caux, C., & Marabelle, A. (2015) · Mutagenesis · doi:10.1093/mutage/geu073 · Cited by 64
Gandhi, S., & Chandna, S. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9669-x · Cited by 64
Immune modulation in advanced radiotherapies: Targeting out-of-field effects
Hanna, G. G., Coyle, V., & Prise, K. M. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.04.007 · Cited by 57
Radiation-Induced Transformation of Immunoregulatory Networks in the Tumor Stroma
Martínez-Zubiaurre, I., Chalmers, A. J., & Hellevik, T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01679 · Cited by 57
Antiangiogenic therapy: Markers of response, “normalization” and resistance
Alaoui‐Lasmaili, K. E., & Faivre‐Fiorina, B. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.06.001 · Cited by 55
Radiation-induced changes in the glycome of endothelial cells with functional consequences
Jaillet, C., Morelle, W., Slomianny, M., Paget, V., Tarlet, G., Buard, V., Selbonne, S., Caffin, F., Rannou, E., Martinez, P., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05563-y · Cited by 47
Smolarczyk, R., Cichoń, T., Pilny, E., Jarosz–Biej, M., Poczkaj, A., Kułach, N., & Szala, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-25688-y · Cited by 46
Self-citationThe importance of correctly timing cancer immunotherapy
Nejad, E. B., Welters, M. J. P., Arens, R., & van der Burg, S. H. (2016) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1256388 · Cited by 40
Bockel, S., Durand, B., & Deutsch, É. (2018) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2018.07.136 · Cited by 36
Radioresistance of cancer cells, integrin αvβ3 and thyroid hormone
Leith, J. T., Mousa, S. A., Hercbergs, A. A., Lin, H., & Davis, P. J. (2018) · Oncotarget · doi:10.18632/oncotarget.26434 · Cited by 33
Innate lymphoid cells as regulators of the tumor microenvironment
Tugues, S., Ducimetière, L., Friebel, E., & Becher, B. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.03.002 · Cited by 32
Immuno-oncology: Allying forces of radio- and immuno-therapy to enhance cancer cell killing
Bernier, J. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.11.001 · Cited by 31
Radiotherapy as a New Player in Immuno-Oncology
Wang, S.-J., & Haffty, B. G. (2018) · Cancers · doi:10.3390/cancers10120515 · Cited by 31
Tsoutsou, P. P., Zaman, K., Lluesma, S. M., Cagnon, L., Kandalaft, L. E., & Vozenin, M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00609 · Cited by 25
Radiation meets immunotherapy – a perfect match in the era of combination therapy?
Soukup, K., & Wang, X. (2015) · International Journal of Radiation Biology · doi:10.3109/09553002.2014.995383 · Cited by 24
Kouam, P. N., Bühler, H., Hero, T., & Adamietz, I. U. A. (2019) · Radiation Oncology · doi:10.1186/s13014-019-1230-3 · Cited by 24
Deplanque, G., Shabafrouz, K., & Obéid, M. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-2000-4 · Cited by 22
Sun, X., Deng, L., & Lü, Y. (2018) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2018.01.15 · Cited by 20
Following the Preclinical Data: Leveraging the Abscopal Effect More Efficaciously
Ngwa, W. F., & Ouyang, Z. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00066 · Cited by 16
Polarization of Tumor Milieu: Therapeutic Implications
Szala, S., Jarosz–Biej, M., Cichoń, T., Smolarczyk, R., & Sochanik, A. (2014) · Springer eBooks · doi:10.1007/978-3-662-44946-2_22 · Cited by 4
Self-citation
Cited by
Radiotherapy combined with immunotherapy: the dawn of cancer treatment
Zhang, Z., Liu, X., Chen, D., & Yu, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01102-y · Cited by 670
Nanozymes-recent development and biomedical applications
Ren, X., Chen, D., Wang, Y., Li, H., Zhang, Y., Chen, H., Li, X., & Huo, M. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01295-y · Cited by 456
Three-Dimensional Spheroids as In Vitro Preclinical Models for Cancer Research
Pinto, B., Henriques, A. C., Silva, P. M. A., & Bousbaa, H. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121186 · Cited by 440
Programmed Cell Death Tunes Tumor Immunity
Liu, J., Hong, M., Li, Y., Chen, D., Wu, Y., & Hu, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.847345 · Cited by 316
The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited
Dzobo, K., Senthebane, D. A., & Dandara, C. (2023) · Cancers · doi:10.3390/cancers15020376 · Cited by 146
Metadata
- Authors
- Jarosz-Biej, M., Smolarczyk, R., Cichoń, T., & Kułach, N.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-06-29
- Volume
- 20
- Issue
- 13
- Pages
- 3212
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2955294253
- Cited by
- 546
- References
- 133
- FWCI
- 18.50
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.